InvestorsHub Logo
Replies to #33 on Viatris (VTRS)

DewDiligence

01/09/16 10:32 AM

#34 RE: DewDiligence #33

MYL-MNTA partnership includes MNTA’s Orencia FoB plus five undisclosed FoB compounds from MNTA’s pipeline. It excludes the Humira FoB MNTA is developing with BXLT.

DewDiligence

01/09/16 10:37 AM

#35 RE: DewDiligence #33

MYL-MNTA FoB partnerhsip is fully separate from MYL's FoB partnership with Biocon, which includes FoBs for Herceptin, Neulasta, Avastin, Humira, Enbrel, and insulin analogs (#msg-72421544, #msg-84561737).